REFERENCES
- Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Medical eligibility criteria for contraceptive use (UKMEC 2009). London: 2009.
- Stevens-Simon C, Kelly L, Kulick R. A village would be nice but… it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am J Prev Med 2001;21:60–5.
- Goodman S, Hendlish SK, Reeves MF, . Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78:143–8.
- Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception 2008;78:149–54.
- Lader D. Contraception and sexual health. Opinions Survey Report No. 41, produced by the Office for National Statistics on behalf of the Department of Health, London: Office for National Statistics 2008/09.
- National Institute for Health and Clinical Excellence (NICE). Long-acting reversible contraception: The effective and appropriate use of long-acting reversible contraception. London, UK: RCOG Press 2005. Accessed 17 June 2011 from: http://www.nice.org.uk/nicemedia/live/10974/29912/29912.pdf
- Glasier A, Scorer J, Bigrigg A. Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. J Fam Plann Reprod Health Care 2008;34:213–7.
- Whitaker AK, Johnson LM, Harwood B, . Adolescent and young adult women’s knowledge of and attitudes toward the intrauterine device. Contraception 2008;78:211–7.
- Mansour D, Rosales C, Cox M. Women's awareness of long-acting, reversible contraceptive methods (LARCs) in community family planning clinics and general practice. Eur J Contracept Reprod Health Care 2008;13: 396–9.
- Conover WJ. Some methods based on ranks. In Conover WJ, ed. Practical nonparametric statistics, 3rd edn. New York, NY: Wiley 1999:387–95.
- Sheeran P, Abraham C, Orbell S. Psychosocial correlates of heterosexual condom use: a meta-analysis. Psychol Bull 1999;125:90–132.
- Power J, French R, Cowan F. Sub-dermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2007; 3:CD001326.
- Kulier R, O’Brien P, Helmerhorst FM, . Copper containing, framed intrauterine devices for contraception. Cochrane Database Syst Rev 2007;4:CD00.
- Faculty of Family Planning and Reproductive Health Care, Clinical Effectiveness Unit. Management of unscheduled bleeding in women using hormonal contraception. London: 2009.
- Allen RH, Bartz D, Grimes DA, . Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009;3:CD007373.
- Wellings K, Zhihong Z, Krentel A, . Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 2007;76:208–14.
- Brown S, Guthrie K. Why don't teenagers use contraception? A qualitative interview study. Eur J Contracept Reprod Health Care 2010;15:197–204.
- World Contraceptive Use 2011. United Nations, Department of Economic and Social Affairs, Population Division. Accessed 4 November 2011 from: http://www.un.org/esa/population/publications/contraceptive2011/wallchart_front.pdf
- Suhonen S, Haukkamaa M, Jakobsson T, . Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004;69:407–12.
- Backman T, Huhtala S, Luoto R, . Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 2002;99:608–13.
- Hubacher D, Goco N, Gonzalez B, Taylor D. Factors affecting continuation rates of DMPA. Contraception 1999;60:345–51.
- Canto De Cetina TE, Canto P, Ordoñez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception 2001;63:143–6.
- My contraception tool. Accessed 7 April 2011 from: http://www.lshtm.ac.uk/news/2010/mycontraceptiontool.html